Discontinuation report NAT-OMEPRAZOLE DR
| Report ID | 273440 |
| Drug Identification Number | 02439549 |
| Brand name | NAT-OMEPRAZOLE DR |
| Common or Proper name | OMEPRAZOLE |
| Company Name | NATCO PHARMA (CANADA) INC |
| Market Status | MARKETED |
| Active Ingredient(s) | OMEPRAZOLE |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 & 500 BOTTLE |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2025-12-05 |
| Remaining supply date | 2025-12-05 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-12-05 | French | Compare |
| v2 | 2025-12-05 | English | Compare |
| v1 | 2025-12-05 | English | Compare |
Showing 1 to 3 of 3